Distribution of Bevacizumab into the Cerebrospinal Fluid of Children and Adolescents with Recurrent Brain Tumors.
Iris K MinichmayrUrsula KnaackJohannes GojoDaniel SenfterChristine HaberlerAmedeo A AziziLisa MayrMarkus ZeitlingerAndreas PeyrlPublished in: Paediatric drugs (2024)
This pharmacokinetic pilot study indicated penetration of bevacizumab into the CSF in a population of children, adolescents, and young adults with recurrent brain tumors.